148 related articles for article (PubMed ID: 19656169)
21. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease.
Holan KR; Holzbach RT; Hermann RE; Cooperman AM; Claffey WJ
Gastroenterology; 1979 Oct; 77(4 Pt 1):611-7. PubMed ID: 467918
[TBL] [Abstract][Full Text] [Related]
22. The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man.
Carey MC; Small DM
J Clin Invest; 1978 Apr; 61(4):998-1026. PubMed ID: 659586
[TBL] [Abstract][Full Text] [Related]
23. Cholesterol saturation rather than phospholipid/bile salt ratio or protein content affects crystallization sequences in human gallbladder bile.
Venneman NG; Portincasa P; Vanberge-Henegouwen GP; van Erpecum KJ
Eur J Clin Invest; 2004 Oct; 34(10):656-63. PubMed ID: 15473890
[TBL] [Abstract][Full Text] [Related]
24. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease.
Yago MD; González V; Serrano P; Calpena R; Martínez MA; Martínez-Victoria E; Mañas M
Nutrition; 2005 Mar; 21(3):339-47. PubMed ID: 15797676
[TBL] [Abstract][Full Text] [Related]
25. Serum and bile lipids in young women with radiolucent gallstones.
Cavallini A; Messa C; Mangini V; Argese V; Misciagna G; Giorgio I
Am J Gastroenterol; 1987 Dec; 82(12):1279-82. PubMed ID: 3687905
[TBL] [Abstract][Full Text] [Related]
26. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
Gustafsson U; Sahlin S; Einarsson C
Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325
[TBL] [Abstract][Full Text] [Related]
27. Hepatic bile versus gallbladder bile: a comparison of protein and lipid concentration and composition in cholesterol gallstone patients.
Keulemans YC; Mok KS; de Wit LT; Gouma DJ; Groen AK
Hepatology; 1998 Jul; 28(1):11-6. PubMed ID: 9657090
[TBL] [Abstract][Full Text] [Related]
28. Biochemical epidemiology of gallbladder cancer.
Strom BL; Soloway RD; Rios-Dalenz J; Rodriguez-Martinez HA; West SL; Kinman JL; Crowther RS; Taylor D; Polansky M; Berlin JA
Hepatology; 1996 Jun; 23(6):1402-11. PubMed ID: 8675157
[TBL] [Abstract][Full Text] [Related]
29. Cholesterol, non-cholesterol sterols and bile acids in paediatric gallstones.
Koivusalo AI; Pakarinen MP; Sittiwet C; Gylling H; Miettinen TA; Miettinen TE; Nissinen MJ
Dig Liver Dis; 2010 Jan; 42(1):61-6. PubMed ID: 19632165
[TBL] [Abstract][Full Text] [Related]
30. Effect of deoxycholate on immunoglobulin G concentration in bile: studies in humans and pigs.
Sanabria JR; Upadhya A; Mullen B; Harvey PR; Strasberg SM
Hepatology; 1995 Jan; 21(1):215-22. PubMed ID: 7806157
[TBL] [Abstract][Full Text] [Related]
31. The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease.
Smit JW; van Erpecum KJ; Renooij W; Stolk MF; Edgar P; Doornewaard H; Vanberge-Henegouwen GP
Hepatology; 1995 Jun; 21(6):1523-9. PubMed ID: 7768495
[TBL] [Abstract][Full Text] [Related]
32. Association between cholesterol-phospholipid vesicles and cholesterol crystals in human gallbladder bile.
Schriever CE; Jüngst D
Hepatology; 1989 Apr; 9(4):541-6. PubMed ID: 2925158
[TBL] [Abstract][Full Text] [Related]
33. Noncholesterol sterols in bile and stones of patients with cholesterol and pigment stones.
Miettinen TE; Kesäniemi YA; Gylling H; Järvinen H; Silvennoinen E; Miettinen TA
Hepatology; 1996 Feb; 23(2):274-80. PubMed ID: 8591852
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of gallstones.
Carey MC
Recenti Prog Med; 1992; 83(7-8):379-91. PubMed ID: 1529152
[TBL] [Abstract][Full Text] [Related]
35. Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones.
Nakano K; Chijiiwa K
Gut; 1993 May; 34(5):702-7. PubMed ID: 8504975
[TBL] [Abstract][Full Text] [Related]
36. [Cholesterol crystals, cholesterol saturation of bile and biliary lithiasis].
Poupon R; Chrétien Y; Darnis F
Gastroenterol Clin Biol; 1984 Mar; 8(3):260-3. PubMed ID: 6714561
[TBL] [Abstract][Full Text] [Related]
37. Cholesterol and pigment gallstone disease: comparison of the reliability of three bile tests for differentiation between the two stone types.
van Erpecum KJ; van Berge Henegouwen GP; Stoelwinder B; Stolk MF; Eggink WF; Govaert WH
Scand J Gastroenterol; 1988 Oct; 23(8):948-54. PubMed ID: 3201132
[TBL] [Abstract][Full Text] [Related]
38. The relation between biliary lipids, nucleation time, and number of gallbladder stones after percutaneous gallbladder puncture.
Tudyka J; Kratzer W; Maier C; Mason R; Wechsler JG
Scand J Gastroenterol; 1994 Sep; 29(9):844-8. PubMed ID: 7824866
[TBL] [Abstract][Full Text] [Related]
39. High vesicular cholesterol and protein in bile are associated with formation of cholesterol but not pigment gallstones.
Chijiiwa K; Hirota I; Noshiro H
Dig Dis Sci; 1993 Jan; 38(1):161-6. PubMed ID: 8420750
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: soluble pronucleating proteins in gallbladder and hepatic biles.
van Erpecum KJ; Wang DQ; Lammert F; Paigen B; Groen AK; Carey MC
J Hepatol; 2001 Oct; 35(4):444-51. PubMed ID: 11682027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
